ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.86
0.52%
US Tech 100
17,009.60
0.88%
S&P 500
5,052.87
0.69%
US Dollar vs CAD
1.36859
-0.28%
Bitcoin
59,036.16
1.37%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Molecular Templates Inc (MTEM)

  7. Molecular Templates Inc (MTEM) News

MTEM Molecular Templates Inc

1.6848
0.0348 (2.11%)
Last Updated: 12:09:11
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Molecular Templates Inc MTEM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.0348 2.11% 1.6848 12:09:11
Open Price Low Price High Price Close Price Previous Close
1.64 1.55 1.6876 1.65
more quote information »

Recent News

Date Time Source Heading
4/09/202407:11GLOBEMolecular Templates Presents Interim Data from MT-6402 Phase..
3/29/202407:21GLOBEMolecular Templates, Inc. Reports Fourth Quarter 2023..
3/28/202407:11GLOBEMolecular Templates Announces $9.5 Million Private Placement..
3/04/202407:11GLOBEMolecular Templates, Inc. Provides Interim Update
2/14/202419:39EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202415:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/08/202416:55GLOBEMolecular Templates to Present at Oppenheimer 34th Annual..
1/25/202416:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/25/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/17/202415:04EDGAR2Form 8-K - Current report
11/13/202315:13EDGAR2Form 8-K - Current report
11/13/202315:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202315:11GLOBEMolecular Templates, Inc. Reports Third Quarter 2023..
11/02/202315:11GLOBEMolecular Templates Announces First Patient Dosed in Phase 1..
11/01/202315:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202315:12GLOBEMolecular Templates to Participate in Upcoming Investor..
10/31/202317:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/31/202317:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/31/202317:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/31/202317:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/31/202317:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/31/202317:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/27/202315:12EDGAR2Form 8-K - Current report
10/06/202316:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
9/28/202316:01EDGAR2Form 8-K - Current report
9/28/202315:11GLOBEMolecular Templates Announces the Appointment of Dr...
9/12/202316:15EDGAR2Form ARS - Annual Report to Security Holders
9/12/202316:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
9/12/202316:08EDGAR2Form DEF 14A - Other definitive proxy statements
8/31/202317:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/31/202315:11EDGAR2Form 8-K - Current report
8/11/202315:12EDGAR2Form 8-K - Current report
8/11/202310:22GLOBEMolecular Templates Announces 1-for-15 Reverse Stock Split
8/10/202308:01EDGAR2Form S-3 - Registration statement under Securities Act of..
8/10/202307:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202307:09EDGAR2Form 8-K - Current report
8/10/202307:08GLOBEMolecular Templates, Inc. Reports Second Quarter 2023..
8/02/202315:16EDGAR2Form 8-K - Current report
8/02/202315:11GLOBEMolecular Templates Announces Executive Leadership Changes
7/18/202310:56EDGAR2Form DEF 14A - Other definitive proxy statements
7/13/202311:48EDGAR2Form 8-K - Current report
7/13/202307:14GLOBEMolecular Templates Announces Up to $40 Million Private..
6/30/202315:31EDGAR2Form PRE 14A - Other preliminary proxy statements
6/16/202319:56GLOBEMolecular Templates Announces Debt Payoff and Restructuring
6/01/202306:57GLOBEMolecular Templates Announces the FDA Removal of Partial..
5/26/202316:10GLOBEMolecular Templates to Present on Phase I Dose Escalation..
5/15/202315:13GLOBEMolecular Templates, Inc. Reports First Quarter 2023..

Your Recent History

NASDAQ
MTEM
Molecular Templates
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved